The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it ...
Dozens of new discoveries reveal that defenses evolved by bacteria and viruses billions of years ago still define our own ...
UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of ...
Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...
Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...
About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel ...
Dragons are some of the most iconic monsters in D&D; here's which types of the flying leviathans are the most horrifying to ...
An inspiring story of resilience, determination, and academic excellence has come to light following the declaration of the ...
Programmable cell‑like particles seek out drug‑resistant bacteria, inject lethal payloads, and spare beneficial microbes.
Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are ...
But some antibiotics may also push bacteria to release tiny particles that can make inflammation worse. While inflammation is part of the body’s natural defense against infection, too much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results